Characteristics of mortal COVID-19 cases compared to the survivors

Xianghui Zhou1,2, Zhipeng Cheng1,2, Dan Shu3

  • 1Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Aging
|November 25, 2020
PubMed

Insights

Certain comorbidities and elevated inflammatory markers like C-reactive protein predict severe outcomes in patients with coronavirus disease 2019 (COVID-19). These factors, along with coagulation indicators, are crucial for understanding COVID-19 mortality risk.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Critical Care Medicine

Background:

  • The global emergence of coronavirus disease 2019 (COVID-19) has led to significant mortality and public health concerns.
  • Identifying risk factors for COVID-19 mortality is crucial for effective clinical management and resource allocation.

Purpose of the Study:

  • To conduct a meta-analysis exploring risk factors associated with mortality in patients diagnosed with COVID-19.
  • To identify key comorbidities, laboratory markers, and medical interventions that predict poor prognosis in COVID-19.

Main Methods:

  • A systematic literature search was performed across PubMed, EMBASE, and CNKI databases up to August 10, 2020.
  • Data from 19 selected studies were extracted and analyzed using a meta-analysis approach with Stata 16.0 software.

Main Results:

  • Comorbidities including diabetes, hypertension, malignancies, COPD, cardio-cerebrovascular disease, and chronic liver disease were significantly more prevalent in fatal COVID-19 cases.
  • Elevated coagulation markers (e.g., D-dimer, platelet count) and inflammatory markers (e.g., C-reactive protein, IL-6) were associated with disease deterioration.
  • The need for extracorporeal membrane oxygenation (ECMO) and mechanical ventilation indicated a poor prognosis.

Conclusions:

  • Specific comorbidities, coagulation indicators, and inflammatory markers are significant predictors of prognosis in COVID-19 patients.
  • Understanding these risk factors can aid clinicians in optimizing treatment strategies to reduce COVID-19 mortality.
  • The findings highlight the complex interplay of host factors and disease progression in severe COVID-19 cases.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
420
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
494
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
63.4K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
272
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K